Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
DaVita
DVA
$11.4B
| $36.8M | 0.03% |
+645,097
| New | +$37.5M |
|
627
MGE Energy Inc
MGEE
$3.06B
| $36.8M | 0.03% |
460,850
+5,500
| +1% | +$411K |
|
628
Urban Edge Properties
UE
$2.78B
| $36.8M | 0.03% |
1,857,300
+794,000
| +75% | +$14.1M |
|
629
Reliance Steel & Aluminium
RS
$21.7B
| $36.7M | 0.03% |
368,612
+224,100
| +155% | +$21.9M |
|
630
US Physical Therapy
USPH
$1.24B
| $36.7M | 0.03% |
281,113
-84,623
| -23% | -$11M |
|
631
United Microelectronic
UMC
$48.6B
| $36.5M | 0.03% |
17,460,138
+435,949
| +3% | +$930K |
|
|
NAV
632
DELISTED
Navistar International
NAV
| $36.5M | 0.03% |
1,296,804
+261,504
| +25% | +$7.43M |
|
633
Northwest Natural Holdings
NWN
$2.14B
| $36.4M | 0.03% |
510,500
-61,600
| -11% | -$4.37M |
|
634
Ituran Location and Control
ITRN
$1.06B
| $36.4M | 0.03% |
1,468,800
+27,000
| +2% | +$766K |
|
|
CSFL
635
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $36.3M | 0.03% |
1,514,942
-209,500
| -12% | -$4.89M |
|
636
Stellantis
STLA
$20.2B
| $36.2M | 0.03% |
2,799,289
+420,595
| +18% | +$5.63M |
|
637
World Acceptance Corp
WRLD
$875M
| $36.2M | 0.03% |
284,000
+35,400
| +14% | +$5.01M |
|
638
SPS Commerce
SPSC
$2.86B
| $36.2M | 0.03% |
768,044
-89,816
| -10% | -$4.56M |
|
639
J.M. Smucker
SJM
$12.9B
| $36.1M | 0.03% |
328,480
+183,077
| +126% | +$20.4M |
|
|
WBC
640
DELISTED
WABCO HOLDINGS INC.
WBC
| $36.1M | 0.03% |
269,600
+46,805
| +21% | +$6.22M |
|
|
DMC
641
Del Monte Corp
DMC
$1.44B
| $36M | 0.03% |
1,055,500
-75,800
| -7% | -$2.15M |
|
|
AKRX
642
DELISTED
Akorn Inc
AKRX
| $35.9M | 0.03% |
9,453,869
+905,699
| +11% | +$3.24M |
|
643
CarGurus
CARG
$3.38B
| $35.8M | 0.03% |
1,157,300
-345,600
| -23% | -$11.8M |
|
644
Barrett Business Services
BBSI
$800M
| $35.8M | 0.03% |
1,610,800
+1,200
| +0.1% | +$26.1K |
|
645
Stepan Co
SCL
$1.48B
| $35.7M | 0.03% |
368,000
+36,200
| +11% | +$3.43M |
|
|
SASR
646
DELISTED
Sandy Spring Bancorp Inc
SASR
| $35.7M | 0.03% |
1,059,578
+7,137
| +0.7% | +$247K |
|
|
CUK
647
DELISTED
Carnival PLC
CUK
| $35.7M | 0.03% |
848,000
+41,300
| +5% | +$1.84M |
|
|
CLDT
648
Chatham Lodging
CLDT
$601M
| $35.6M | 0.03% |
1,959,876
+232,576
| +13% | +$4.13M |
|
649
Carlisle Companies
CSL
$14.9B
| $35.3M | 0.03% |
242,700
+169,600
| +232% | +$23.8M |
|
650
Regions Financial
RF
$27B
| $35.3M | 0.03% |
2,230,321
+1,396,600
| +168% | +$21.1M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.